VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 24 filers reported holding VASCULAR BIOGENICS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $128,000 | -5.2% | 100,000 | 0.0% | 0.02% | -16.0% |
| Q1 2020 | $135,000 | +187.2% | 100,000 | +185.7% | 0.02% | +150.0% |
| Q3 2019 | $47,000 | +2.2% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $46,000 | +84.0% | 35,000 | +216.7% | 0.01% | +66.7% |
| Q1 2019 | $25,000 | 0.0% | 11,050 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $25,000 | -67.9% | 11,050 | 0.0% | 0.01% | -68.4% |
| Q4 2017 | $78,000 | +16.4% | 11,050 | 0.0% | 0.02% | +11.8% |
| Q3 2017 | $67,000 | +9.8% | 11,050 | 0.0% | 0.02% | -15.0% |
| Q1 2017 | $61,000 | +13.0% | 11,050 | 0.0% | 0.02% | +11.1% |
| Q4 2016 | $54,000 | +5.9% | 11,050 | 0.0% | 0.02% | +5.9% |
| Q2 2016 | $51,000 | +34.2% | 11,050 | 0.0% | 0.02% | +41.7% |
| Q1 2016 | $38,000 | -34.5% | 11,050 | 0.0% | 0.01% | -36.8% |
| Q4 2015 | $58,000 | -30.1% | 11,050 | 0.0% | 0.02% | -32.1% |
| Q3 2015 | $83,000 | +22.1% | 11,050 | 0.0% | 0.03% | +27.3% |
| Q2 2015 | $68,000 | – | 11,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spectrum Planning & Advisory Services Inc. | 16,000 | $2,681 | 0.00% |
| Virtu Financial LLC | 37,424 | $6 | 0.00% |
| Affinity Capital Advisors, LLC | 22,265 | $3,729 | 0.00% |
| MORGAN STANLEY | 409,011 | $68,509 | 0.00% |
| HBK Sorce Advisory LLC | 20,575 | $3,447 | 0.00% |
| Bank of New York Mellon Corp | 39,000 | $6,533 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $2 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 937 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 798 | $0 | 0.00% |